Condition
Ischaemia-reperfusion Injury
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 3 (1)
P 4 (2)
Trial Status
Unknown3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04203004Not ApplicableUnknown
HOPE With Cytokine Filtration in Liver Transplantation (Cyto-HOPE)
NCT02299063Phase 4Unknown
Dexmedetomidine Effect on Mitochondrial Function
NCT01780740Phase 4Completed
Statin Therapy In Atrial Refractoriness and Reperfusion Injury
NCT01771978Phase 3UnknownPrimary
Ischaemia-réperfusion During the Coronary Surgery With Beating Heart
Showing all 4 trials